sold 28 millionshares in BM&FBOVESPASA, reducing its stake in the Brazilian stock exchange operator to2.4% from 4.0%, BM&FBOVESPA said in an Oct. 6 release.

This saledoes not change the terms of the strategic partnership between the twocompanies involving cross listing products and technological cooperation, theBrazilian company noted. Additionally, CME will continue to appoint a member tothe BM&FBOVESPA board of directors, as long as it holds a minimum 2% stake.